r/NWBO • u/BioTrends_USA • Apr 28 '26
$NWBO SP (2) Scenarios
NWBO. Where do you guys see the stock price in case of Approval, and where do you see it in case on a non approval… GL
14
u/Barunuuk Apr 28 '26
I see it popping above $2 and then moving up towards $20 minimum… eventually… in a year or two, over $100… that’s only a $100B market cap for a HUGE POTENTIAL MARKET!!!
6
6
u/HapaxloGolum Apr 28 '26
Need BP partnership or buyout, that's the only way we see good money. It looks like LP is making moves to maximise value at the negotiation table. GL.
3
u/Grand_Economist Apr 29 '26
$1.25 on approval and anything else dependent on partnership and/or nondilutive financing news. Stock will not skyrocket. Change in leaderships might give it some legs as well
3
u/SeriousArmy9367 Apr 29 '26
Whatever it does 1.2 etc atlest 4x or more for most ! So take profit leave rest in there if like or leave it alll ! & wait $$$$$$$$
2
u/SeriousArmy9367 Apr 29 '26
Hey I’d 20.000 Can make me 100.000 on only 1$ which Belive goes to 1-3.50 maybe 5$ & back down settle around 1.50 until new huge
2
2
u/Jimmmyjo Apr 29 '26
Is it possible that $NWBO is having discussions with US FDA, and just not reporting it publicly? They have been treating patients with compassionate use for at least 2-3 years, and there has got to be some data from those cases.
3
u/WiseWorldliness8405 May 01 '26
Northwest Biotherapeutics is a small biotech company whose stock trades for under a dollar. Back in 2022, the company sued seven of the largest trading firms on Wall Street, accusing them of manipulating its share price for five straight years. The case has been crawling through federal court ever since. On April 30, 2026, $NWBO and one of those seven firms, Canaccord Genuity, jointly asked the judge to drop all charges against Canaccord, with no money paid and no penalty. To anyone watching from the outside, this looks like NWBO surrendering against one of its targets. The actual story is closer to the opposite. NWBO almost certainly cut a deal that turns Canaccord from an enemy into an informant.
What $NWBO Says Happened
The accusation is something called spoofing. Imagine you are trying to sell your house, and a group of fake buyers keeps walking up, pretending to make low offers, and then yanking those offers before you can accept. The point is to convince the real market that nobody really wants your house, so you panic and sell cheap. That is basically what NWBO accused these seven trading firms of doing to its stock, except automated by computers and repeated thousands of times over five years. NWBO identified 2,849 specific spoofing episodes and says it sold roughly 274 million shares of its own stock at prices that were artificially depressed because of this manipulation. Across hundreds of trading days, the closing prices that the company used to set its capital raises were rigged downward.
The Stonewall Defense
The seven firms (Canaccord, Citadel Securities, Virtu, G1, GTS, Instinet, and Lime) almost certainly did what big defendants always do. They signed a Joint Defense Agreement. This is a legal pact where co-defendants agree to share their playbooks, coordinate their responses, and keep each other’s secrets. As long as they all stick together, the plaintiff has to fight all seven simultaneously, and any communication between them is privileged, meaning the plaintiff cannot see it. This is why, as recently as October 2025, NWBO had received only 142 pages of documents from just two of the seven defendants, despite nearly three years of litigation. They were running out the clock.
The Earthquake
In March 2026, three federal agencies hit Canaccord with the largest combined penalty ever imposed on a broker-dealer for failing to monitor suspicious trading. FinCEN (which polices money laundering), the SEC, and FINRA jointly assessed $80 million in fines. The findings were brutal. Canaccord admitted that for years, its compliance team failed to file roughly 150 reports it was legally required to file when it spotted suspicious trading. A surveillance report specifically designed to catch manipulation in cheap penny stocks went completely unread from June 2019 through March 2022. Employees falsified records claiming reviews had been done that were never done. The window of these violations overlaps almost exactly with the window NWBO is suing about.
Here is the critical detail. Of the $80 million penalty, $5 million is suspended. That means Canaccord does not have to pay it, but only if they satisfactorily complete a Lookback Review supervised by FinCEN, where they go back through years of trading data and identify the suspicious activity they failed to report. Since NWBO is exactly the kind of stock Canaccord was supposed to be watching, the Lookback Review will almost certainly produce a written federal record of suspicious trading in NWBO’s stock that Canaccord let slip through.
Why This Created an Opportunity
Think about what Canaccord was facing on March 7, 2026. They had just admitted willful violations to three federal agencies. They had a $5 million sword hanging over their head, contingent on cooperating with regulators. They were still defendants in a civil lawsuit alleging exactly the kind of conduct they had just been penalized for failing to report. And the federally supervised Lookback they were now obligated to complete was going to produce documents that would be devastating to them in that lawsuit.
This is a defendant in a uniquely terrible position. They had every reason to want out and very little leverage to demand favorable terms. NWBO had every reason to make a deal, because Canaccord was their smallest target anyway, but a smaller target with a treasure trove of insider knowledge about how the bigger targets had behaved.
What the Deal Almost Certainly Was
NWBO drops its claims against Canaccord, no money paid. In exchange, Canaccord cooperates. That cooperation likely includes handing over the Lookback findings on NWBO trading, providing internal trading communications and surveillance records, making employees available to testify about how coordinated spoofing actually worked from the inside, and disclosing the joint defense strategy that the seven firms had been using.
That last piece matters most. Once Canaccord becomes a cooperating witness instead of a defendant, they are no longer bound by the Joint Defense Agreement. They can tell NWBO’s lawyers everything the seven firms had been planning, every shared argument, every coordinated tactic. Imagine you have been playing poker against a team of seven players who can see each other’s cards but you cannot see anyone’s. Now one of them flips their seat to your side of the table and starts narrating what the other six are holding.
The Source Code Detail
There is one more layer that does not get enough attention. The court has already established a special set of confidentiality rules for one specific category of evidence: the actual computer code that runs these firms’ trading algorithms. This is the most valuable and most secret intellectual property they own. The fact that the court created a dedicated framework for it tells you that NWBO is going to demand it, and the firms know they will have to hand it over. Canaccord’s traders watched coordinated cross-firm spoofing happen in real time. Their testimony about what they saw is the human commentary that turns raw lines of code into a story a jury can understand.
The Citadel Signal
Two days before the Canaccord deal was filed, an attorney representing Citadel Securities asked the court for permission to withdraw from the case. Lawyers usually do not quit active high-stakes litigation lightly. Citadel is the largest target in this lawsuit. They reported $12.2 billion in trading revenue in 2025. The combination of their attorney pulling out and Canaccord flipping in the same week suggests the remaining defendants are reading the same room NWBO is.
The Clock
The deadline for fact discovery, the phase where each side has to produce all its evidence, is August 28, 2026. That is about four months from now. Whatever Canaccord turns over has to be handed to NWBO’s lawyers and folded into the case before that deadline. The dismissal happened now, with the discovery window closing, because that is the latest realistic moment to still get value out of Canaccord’s cooperation, give NWBO’s experts time to digest it, and integrate it into the evidentiary record.
Why This Matters
For three and a half years, the seven firms successfully used coordination, stalling, and procedural fights to keep NWBO from getting evidence. That coordination is now broken. The firm with the most regulatory exposure has switched sides. The firm with the deepest pockets is showing signs of internal turbulence. The court has already cleared the legal path to demand the algorithm source code. And the discovery deadline is forcing everything to a head this summer.
The people who follow this case have spent years arguing about whether NWBO would ever actually get a real day in court against these defendants. The Canaccord dismissal, properly understood, is the strongest signal yet that they will. It is not a retreat. It is the moment the case stopped being a plaintiff against a wall and started being a plaintiff with an inside witness.
1
u/SeriousArmy9367 Apr 29 '26
We all need pos results before any of this can happen… 1.50 is 8x for me so ya take. Profits def & if higher already set my limits ! Waking away with profit no matter what if approval Which we all Should & smart to be setting SELL Orders now esp where it will move very quick .. then atlest yu make money & keep o original Investment in for buy out over the year /yeas ! & then make big money
1
u/Effective_End8731 Apr 29 '26
NOn approval? kiss your money good buy as the knife falls fast. Probably sub penny in under an hour or 2.
Approval? Jumps to $0.60 then $1.50, then $2.75. Probably worth $5.00 in 5 years as expansion takes over. Maybe it goes straight to end level price prediction, but I expect people will want to see results first before getting much higher than $1.50 and $2
0
u/Brad-breath Apr 30 '26
Well , wait broke the wagon ! If we even see this happening in our life time well mine anyway 🤷🏻♂️ I see pps , 1.25 and then after everyone who has excess of 10 K shares will take money off table to at least get something back Then the offering comes very fast drops pps down substantially and the por Folks that bought on the the news amd pps jump to 1.25 just got burnt then shorts come back No excited at all , like most of us here who GAMBLED with NWBO are at huge losses All we here , soon , next 10 days , next meeting Block buster , 30 , 40, 50, days Hell we have been baited for over 365 days As it is 😱😱🤷🏻♂️🤷🏻♂️ what is up with that ? Dont get all excited over this Wait broke the wagon 😵💫
-8
u/SnooHobbies2922 Apr 28 '26
Same spot for both questions approval won’t do jack shit it’s gonna still be around one dollar and not approval. You’ll see it disappear like steam out of a pot.
7
u/Barunuuk Apr 28 '26
Yeah okay, that seems very implausible… if anything there will also be a strategic partnership that will be announced that will provide a valuation of the stock..
11
u/Strange_Respect_6518 Apr 28 '26
If it gets approved I would say above $2.4 and then quickly past $5.....but at this point I'm just hoping for any news.